Anofi - Net Worth and Insider Trading
Anofi Net Worth
The estimated net worth of Anofi is at least $5.1 Billion dollars as of 2023-03-23. Anofi is the 10% Owner of Translate Bio Inc and owns about 75,668,031 shares of Translate Bio Inc (TBIO) stock worth over $2.8 Billion. Anofi is the 10% Owner of Alnylam Pharmaceuticals Inc and owns about 10,554,134 shares of Alnylam Pharmaceuticals Inc (ALNY) stock worth over $2.0 Billion. Anofi is also the 10% Owner of Regeneron Pharmaceuticals Inc and owns about 279,766 shares of Regeneron Pharmaceuticals Inc (REGN) stock worth over $224 Million. Besides these, Anofi also holds Icosavax Inc (ICVX) , Voyager Therapeutics Inc (VYGR) , Fulcrum Therapeutics Inc (FULC) , Inozyme Pharma Inc (INZY) , MyoKardia Inc (MYOK) . Details can be seen in Anofi 's Latest Holdings Summary section.
Transaction Summary of Anofi
Anofi Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Anofi owns 11 companies in total, including Inozyme Pharma Inc (INZY) , Regeneron Pharmaceuticals Inc (REGN) , and Fulcrum Therapeutics Inc (FULC) among others .
Click here to see the complete history of Anofi ’s form 4 insider trades.
Insider Ownership Summary of Anofi
|Ticker||Comapny||Transaction Date||Type of Owner|
|INZY||Inozyme Pharma Inc||2020-07-23||10 percent owner|
|REGN||Regeneron Pharmaceuticals Inc||2014-01-27||10 percent owner|
|FULC||Fulcrum Therapeutics Inc||2019-07-17||10 percent owner|
|MYOK||MyoKardia Inc||2019-02-13||10 percent owner|
|ALNY||Alnylam Pharmaceuticals Inc||2016-02-01||10 percent owner|
|VYGR||Voyager Therapeutics Inc||2015-11-10||10 percent owner|
|SCYX||SCYNEXIS Inc||2014-05-07||10 percent owner|
|RGLS||Regulus Therapeutics Inc||2014-02-04||10 percent owner|
|GLYC||GlycoMimetics Inc||2013-11-06||10 percent owner|
|HGEN||Humanigen Inc||2012-08-11||10 percent owner|
|ICVX||Icosavax Inc||2021-07-28||10 percent owner|
Anofi Latest Holdings Summary
Anofi currently owns a total of 8 stocks. Among these stocks, Anofi owns 75,668,031 shares of Translate Bio Inc (TBIO) as of September 14, 2021, with a value of $2.8 Billion and a weighting of 55.4%. Anofi owns 10,554,134 shares of Alnylam Pharmaceuticals Inc (ALNY) as of May 31, 2017, with a value of $2.0 Billion and a weighting of 39.4%. Anofi also owns 279,766 shares of Regeneron Pharmaceuticals Inc (REGN) as of June 9, 2020, with a value of $224 Million and a weighting of 4.4%. The other 5 stocks Icosavax Inc (ICVX) , Voyager Therapeutics Inc (VYGR) , Fulcrum Therapeutics Inc (FULC) , Inozyme Pharma Inc (INZY) , MyoKardia Inc (MYOK) have a combined weighting of 0.8100000000000001% among all his current holdings.
Latest Holdings of Anofi
|Ticker||Comapny||Latest Transaction Date||Shares Owned||Current Price ($)||Current Value ($)|
|TBIO||Translate Bio Inc||2021-09-14||75,668,031||37.36||2,826,957,638|
|ALNY||Alnylam Pharmaceuticals Inc||2017-05-31||10,554,134||190.49||2,010,456,986|
|REGN||Regeneron Pharmaceuticals Inc||2020-06-09||279,766||802.16||224,417,095|
|VYGR||Voyager Therapeutics Inc||2015-11-16||2,477,941||7.48||18,534,999|
|FULC||Fulcrum Therapeutics Inc||2019-07-22||558,035||3.14||1,752,230|
|INZY||Inozyme Pharma Inc||2020-07-28||520,125||3.30||1,716,413|
Holding Weightings of Anofi
Anofi Form 4 Trading Tracker
According to the SEC Form 4 filings, Anofi has made a total of 1 transactions in Translate Bio Inc (TBIO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Translate Bio Inc is the acquisition of 71,983,597 shares on September 14, 2021, which cost Anofi around $2.7 Billion.
According to the SEC Form 4 filings, Anofi has made a total of 0 transactions in Alnylam Pharmaceuticals Inc (ALNY) over the past 5 years. The most-recent trade in Alnylam Pharmaceuticals Inc is the acquisition of 297,501 shares on May 31, 2017, which cost Anofi around $21 Million.
According to the SEC Form 4 filings, Anofi has made a total of 7 transactions in Regeneron Pharmaceuticals Inc (REGN) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Regeneron Pharmaceuticals Inc is the sale of 120,234 shares on June 9, 2020, which brought Anofi around $72 Million.More details on Anofi 's insider transactions can be found in the Insider Trading History of Anofi table.
Insider Trading History of Anofi
Anofi Trading Performance
GuruFocus tracks the stock performance after each of Anofi 's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Anofi is -0.79%. GuruFocus also compares Anofi 's trading performance to market benchmark return within the same time period. The performance of stocks bought by Anofi within 3 months outperforms 10 times out of 22 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Anofi 's insider trading performs compared to the benchmark.
Performance of Anofi
Average Relative Return
|1 Month||3 Months||6 Months||1 Year||2 Years||3 Years|
|Relative Return to S&P 500(%)||4.28||-3.7||-3.21||-4.84||-0.17||2.8|
Anofi Ownership Network
Ownership Network List of Anofi
Ownership Network Relation of Anofi
Anofi Owned Company Details
What does Inozyme Pharma Inc do?
Inozyme Pharma Inc is a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue and skeleton. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Its product candidate, INZ-701, is a soluble, recombinant, or genetically engineered, fusion protein that is designed to correct a defect in the mineralization pathway caused by ENPP1 and ABCC6 deficiencies.
Who are the key executives at Inozyme Pharma Inc?
Anofi is the 10 percent owner of Inozyme Pharma Inc. Other key executives at Inozyme Pharma Inc include SVP & CFO Sanjay Subramanian , Interim CFO Stephen J. Dipalma , and SVP & CMO Deborah Wenkert .
Inozyme Pharma Inc (INZY) Insider Trades Summary
Over the past 18 months, Anofi made no insider transaction in Inozyme Pharma Inc (INZY). Other recent insider transactions involving Inozyme Pharma Inc (INZY) include a net purchase of 1,355,000 shares made by Longitude Capital Partners Iii, Llc , a net purchase of 1,070,000 shares made by Robert Lorne Hopfner , and a net purchase of 1,070,000 shares made by Pivotal Bioventure Partners Fund I G.p., L.p. .
In summary, during the past 3 months, insiders sold 0 shares of Inozyme Pharma Inc (INZY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Inozyme Pharma Inc (INZY) were sold and 3,616,950 shares were bought by its insiders, resulting in a net purchase of 3,616,950 shares.
Inozyme Pharma Inc (INZY)'s detailed insider trading history can be found in Insider Trading Tracker table.
NAS:INZY Insider Transactions
Anofi Mailing Address
Above is the net worth, insider trading, and ownership report for Anofi . You might contact Anofi via mailing address: 46 Avenue De La Grande Armee, Paris I0 75017.